C4 Therapeutics, Inc. (CCCC) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $607.0K | +237.2% |
| 2024 | $180.0K | -89.5% |
| 2023 | $1.71M | -68.9% |
| 2022 | $5.50M | +330.4% |
| 2021 | $1.28M | +96.5% |
| 2020 | $650.0K | -51.8% |
| 2019 | $1.35M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $607.0K | +237.2% |
| 2024 | $180.0K | -89.5% |
| 2023 | $1.71M | -68.9% |
| 2022 | $5.50M | +330.4% |
| 2021 | $1.28M | +96.5% |
| 2020 | $650.0K | -51.8% |
| 2019 | $1.35M | — |